Edition:
United States

Genovis AB (GENOb.ST)

GENOb.ST on Stockholm Stock Exchange

2.57SEK
21 Feb 2017
Change (% chg)

0.01kr (+0.39%)
Prev Close
2.56kr
Open
2.58kr
Day's High
2.58kr
Day's Low
2.50kr
Volume
13,806
Avg. Vol
50,775
52-wk High
2.98kr
52-wk Low
1.26kr

GENOb.ST

Chart for GENOb.ST

About

Genovis AB is a Sweden-based company engaged in the research and development, production and marketing of technologies and products for cellular research. The Company offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer,... (more)

Overall

Beta: 0.39
Market Cap(Mil.): kr142.11
Shares Outstanding(Mil.): 55.29
Dividend: --
Yield (%): --

Financials

  GENOb.ST Industry Sector
P/E (TTM): -- 34.58 29.35
EPS (TTM): -0.39 -- --
ROI: -103.83 12.41 12.97
ROE: -104.92 14.40 14.11

BRIEF-Genovis Q3 operating loss narrows to SEK 1.1 mln

* Q3 net sales 4.6 million Swedish crowns ($500,000) versus 3.4 million crowns year ago

Nov 23 2016

BRIEF-Genovis signs a license agreement with Life Technologies Corporation

* Genovis has signed a license agreement with Life Technologies Corporation Source text for Eikon:

Oct 11 2016

BRIEF-Genovis Q2 operating loss widens to SEK 8.0 mln

* Q2 net sales 4.6 million Swedish crowns ($542,433.64) versus 3.5 million crowns year ago

Aug 29 2016

More From Around the Web

Earnings vs. Estimates